Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues NGNE Q1 2026 Earnings EPS Falls Short of Consensus as PreRevenue Biotech Maintains RD Focus Akamai Technologies Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Edges Higher NNE Q1 2026 Earnings Narrower Loss Surprises as Nuclear Innovation Advances MWA Q1 2026 Earnings EPS Surpasses Estimates by 65 Amid Strong Operational Performance TSM Q1 2026 Earnings Earnings Beat Surprises Market but Stock Slips Slightly